Voso, M. T., & Schlenk, R. F. (2020). Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: A subanalysis from the RATIFY trial. Blood advances, 4(19), . https://doi.org/10.1182/bloodadvances.2020002904
Chicago-Zitierstil (17. Ausg.)Voso, Maria Teresa, und Richard Friedrich Schlenk. "Midostaurin in Patients with Acute Myeloid Leukemia and FLT3-TKD Mutations: A Subanalysis from the RATIFY Trial." Blood Advances 4, no. 19 (2020). https://doi.org/10.1182/bloodadvances.2020002904.
MLA-Zitierstil (9. Ausg.)Voso, Maria Teresa, und Richard Friedrich Schlenk. "Midostaurin in Patients with Acute Myeloid Leukemia and FLT3-TKD Mutations: A Subanalysis from the RATIFY Trial." Blood Advances, vol. 4, no. 19, 2020, https://doi.org/10.1182/bloodadvances.2020002904.